Staff Publications

Staff Publications

  • external user (warningwarning)
  • Log in as
  • language uk
  • About

    'Staff publications' is the digital repository of Wageningen University & Research

    'Staff publications' contains references to publications authored by Wageningen University staff from 1976 onward.

    Publications authored by the staff of the Research Institutes are available from 1995 onwards.

    Full text documents are added when available. The database is updated daily and currently holds about 240,000 items, of which 72,000 in open access.

    We have a manual that explains all the features 

Record number 554017
Title Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases
Author(s) Miglianico, Marie; Eldering, Maarten; Slater, Hannah; Ferguson, Neil; Ambrose, Pauline; Lees, Rosemary S.; Koolen, Karin M.J.; Pruzinova, Katerina; Jancarova, Magdalena; Volf, Petr; Koenraadt, Constantianus J.M.; Duerr, Hans Peter; Trevitt, Graham; Yang, Baiyuan; Chatterjee, Arnab K.; Wisler, John; Sturm, Angelika; Bousema, Teun; Sauerwein, Robert W.; Schultz, Peter G.; Tremblay, Matthew S.; Dechering, Koen J.
Source Proceedings of the National Academy of Sciences of the United States of America 115 (2018)29. - ISSN 0027-8424 - p. E6920 - E6926.
Department(s) PE&RC
Laboratory of Entomology
Publication type Refereed Article in a scientific journal
Publication year 2018
Keyword(s) Insecticide - Isoxazoline - Malaria - Vector control - Zika fever

Isoxazolines are oral insecticidal drugs currently licensed fo ectoparasite control in companion animals. Here we propose thei use in humans for the reduction of vector-borne disease incidence Fluralaner and afoxolaner rapidly killed Anopheles, Aedes, an Culex mosquitoes and Phlebotomus sand flies after feeding on drug-supplemented blood meal, with IC50 values ranging from 33 to 575 nM, and were fully active against strains with preexist ing resistance to common insecticides. Based on allometric scalin of preclinical pharmacokinetics data, we predict that a single hu man median dose of 260 mg (IQR, 177–407 mg) for afoxolaner, o 410 mg (IQR, 278–648 mg) for fluralaner, could provide an insecti cidal effect lasting 50–90 days against mosquitoes and Phleboto mus sand flies. Computational modeling showed that seasona mass drug administration of such a single dose to a fraction of regional population would dramatically reduce clinical cases o Zika and malaria in endemic settings. Isoxazolines therefore rep resent a promising new component of drug-based vector control.

There are no comments yet. You can post the first one!
Post a comment
Please log in to use this service. Login as Wageningen University & Research user or guest user in upper right hand corner of this page.